Atlas Trials

A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment

Clinical trial NCT01579019 · WITHDRAWN

Trial details

NCT number
NCT01579019
Sponsor
Hoffmann-La Roche
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2012-07-01
Primary completion
2014-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.